OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-08-31-accounts

Company registration number 02805347 (England and Wales) Charity registration number 1038260 (England and Wales)

OXFORD INTERNATIONAL BIOMEDICAL CENTRE LIMITED ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 AUGUST 2025

OXFORD INTERNATIONAL BIOMEDICAL CENTRE LIMITED

LEGAL AND ADMINISTRATIVE INFORMATION

Trustees M Brooks
C Carr
S Draper
C Kennard
E Sim
R Webber
S Adams (Appointed 10 May 2025)
S Elias (Appointed 10 May 2025)
Secretary K Lewis
Country of incorporation United Kingdom 02805347
(England and Wales)
Charity registration England and Wales 1038260
Registered office 3rd Floor Hathaway House
Popes Drive
London
England
N3 1QF
Independent examiner FMCB Chartered Accountants
3rd Floor
Hathaway House
Popes Drive
Finchley
London
N3 1QF

OXFORD INTERNATIONAL BIOMEDICAL CENTRE LIMITED

CONTENTS

Page
Trustees report 1 - 3
Independent examiner's report 4
Statement of financial activities 5
Balance sheet 6
Statement of cash flows 7
Notes to the financial statements 8 - 15

OXFORD INTERNATIONAL BIOMEDICAL CENTRE LIMITED

TRUSTEES REPORT (INCLUDING DIRECTORS' REPORT) FOR THE YEAR ENDED 31 AUGUST 2025

The trustees present their annual report and financial statements for the year ended 31 August 2025.

The financial statements have been prepared in accordance with the accounting policies set out in note 1 to the financial statements and comply with the charity's governing document, the Companies Act 2006, FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Charities SORP "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)".

Objectives and activities

OIBC's vision is a world in which wider access to scientific learning brings better health and quality of life. It seeks to realise this through educational projects for all generations and especially for the young, building greater understanding of biomedical and other scientific issues.

Its current aim is to increase the number of pupils continuing to study science at school beyond GCSEs and encourage them to consider a career in that subject.

It believes that there is an under-tapped resource of pre-GCSE students. The reason that many lack confidence in their ability to excel because of their or their school's background. This contributes to social immobility. Other causes are dyslexia among some and ignorance of how exciting and rewarding a career in science can be.

To achieve our aim we:

Enthuse through direct contact with scientists at the cutting edge of new discoveries

Educate by explaining what careers in science and other STEM subjects exist and they can be accessed

Encourage by showing that successful scientists often started no better than the students themselves

A feature of the charity is that due to the great enthusiasm of the professional scientific community for promoting science to young people, much time is given for free, ensuring an unusually high output and benefit for every pound donated.

None of the directors take any remuneration, their total expenses for the year amounted to £nil (2024: £nil), and OIBC has but one salaried member of staff.

It is a firm principle of the charity that it sharply constrains administrative costs and ensures it expends all donations received, rather than diverting them to reserves, which it does not require for future functioning.

Public benefit

OIBC always take into account the Charity Commission guidance on public benefit and believes that the activities of Oxford International Biomedical centre are in line with this guidance. The is is underpinned by rigorous feedback sessions with all stakeholders and in particular the schools and colleges with which OIBC works. Their overall message is consistently one of "More Please!".

OXFORD INTERNATIONAL BIOMEDICAL CENTRE LIMITED

TRUSTEES REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 AUGUST 2025

Achievements and performance

Review

The OIBC annual accounts reporting period is geared to the academic year.

This year OIBC worked hard to continue to offer its Scientist in Schools educational programmes and its career talks.

Several events took place including: Little Heath School on 2 December, the annual event at St Edward's School on 22 January, on 'Cutting Edge Science', at Cooper School in Bicester on 31 January, at Didcot Girls School on 5 February, Maths workshop at Swan School on 14 March. In addition, several career talks took place at Aureus School in Didcot.

Our scientists participated in 6 sessions of the after school Medicine Society at Bartholomew School. We also helped organise a two-day event at Oundle School which included workshops on Pandemics and Vaccines.

We run workshops at Bartholomew School and Gosford Hill School (Physics). In July/August 2025 OIBC’s annual Summer School on Global Health took place - USC returned to Oxford with 20 students. We also offered 2 Pasternak Scholarships to students from Senegal. It was a very successful event and USC plan to return in 2026. We are also intending to extend the Pasternak Scholarship to next year.

The annual Anne McLaren lecture took place on 23 May 2025 at Kellogg College and was well attended.

The trustees are confident that OIBC will continue to expand its activities in the future, and they are delighted that OIBC enjoys a successful relationship with Oxford University from which it continued to drive benefit.

Future Development

The charity is now developing ambitious plans to build on its earlier successes by expanding its operational activities within those areas where it already has a presence, and reaching out to additional educational institutions across the country. Board meetings always include a strategic overview component and the growth to date evidences the success of this approach.

Financial review

OIBC continues to hold firmly to its policy of deploying all of its income to the benefit of young people's scientific education and thus applies a policy of not building up reserves.

The overall deficit for the year of £10,405 (2024: deficit £17,487) has been deducted from the general unrestricted fund , which at the balance sheet date stood at £95,823 (2024: £106,228). The Board consider these sums entirely acceptable from both a risk and an operating viewpoint, given the modest size and the financial support on which OIBC can call.

Reserves policy

The policy regarding reserves is to utilise all of it's income for the benefit of scientific education. Any funds retained will be deployed in subsequent years. The trustees are not concerned with any going concern issues as they believe sufficient funds will be generated to carry on the work of the charity going forward.

Structure, governance and management

The charity is a company limited by guarantee without share capital. The governing document is the memorandum and articles of association amended by special resolutions.

OXFORD INTERNATIONAL BIOMEDICAL CENTRE LIMITED

TRUSTEES REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 AUGUST 2025

The trustees, who are also the directors for the purpose of company law, and who served during the year and up to the date of signature of the financial statements were:

M Brooks C Carr R Draper (Resigned 10 May 2025) S Draper C Kennard E Sim R Webber S Adams (Appointed 10 May 2025) S Elias (Appointed 10 May 2025)

Recruitment and appointment of trustees

In order to recruit new trustees that will benefit the charity, the existing board rely on their experience and the guidelines set out by HM Government to ensure that the correct personnel are brought in.

The trustees report was approved by the Board of Trustees.

E Sim

Trustee

13 February 2026

OXFORD INTERNATIONAL BIOMEDICAL CENTRE LIMITED

INDEPENDENT EXAMINER'S REPORT

TO THE TRUSTEES OF OXFORD INTERNATIONAL BIOMEDICAL CENTRE LIMITED

I report to the trustees on my examination of the financial statements of Oxford International Biomedical Centre Limited (the charity) for the year ended 31 August 2025.

Responsibilities and basis of report

As the trustees of the charity (and also its directors for the purposes of company law), you are responsible for the preparation of the financial statements in accordance with the requirements of the Companies Act 2006.

Having satisfied myself that the financial statements of the charity are not required to be audited under Part 16 of the Companies Act 2006 and are eligible for independent examination, I report in respect of my examination of the charity’s financial statements carried out under section 145 of the Charities Act 2011. In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the Charities Act 2011.

Independent examiner's statement

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached.

Daniel Pottesman FMCB Chartered Accountants

3rd Floor Hathaway House Popes Drive Finchley London N3 1QF 16 February 2026

OXFORD INTERNATIONAL BIOMEDICAL CENTRE LIMITED

STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT

FOR THE YEAR ENDED 31 AUGUST 2025

Unrestricted Unrestricted
funds funds
2025 2024
Notes £ £
Income from:
Charitable activities 3 83,741 116,358
Investments 4 1,250 1,923
Total income 84,991 118,281
Expenditure on:
Charitable activities 5 95,396 135,768
Total expenditure 95,396 135,768
Net expenditure and movement in funds (10,405) (17,487)
Reconciliation of funds:
Fund balances at 1 September 2024 106,228 123,715
Fund balances at 31 August 2025 95,823 106,228

The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities.

OXFORD INTERNATIONAL BIOMEDICAL CENTRE LIMITED

BALANCE SHEET

AS AT 31 AUGUST 2025

Notes
Fixed assets
Tangible assets
11
Current assets
Debtors
12
Cash at bank and in hand
Creditors: amounts falling due within
one year
14
Net current assets
Total assets less current liabilities
Creditors: amounts falling due after
more than one year
15
Net assets
The funds of the charity
Unrestricted funds
17		 2025
£
1,769
133,847
135,616
(40,127)		 £
334
95,489
95,823
-
95,823
95,823
95,823		 2024
£
1,769
121,111
122,880
(12,698)		 £
501
110,182
110,683
(4,455)
106,228
106,228
106,228

The company is entitled to the exemption from the audit requirement contained in section 477 of the Companies Act 2006, for the year ended 31 August 2025.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the trustees on 13 February 2026

E Sim Trustee

OXFORD INTERNATIONAL BIOMEDICAL CENTRE LIMITED

STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 AUGUST 2025

Notes
Cash flows from operating activities
Cash generated from/(absorbed by)
operations
19
Investing activities
Purchase of tangible fixed assets
Investment income received
Net cash generated from investing activities
Financing activities
Repayment of bank loans
Net cash used in financing activities
Net increase/(decrease) in cash and cash
equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year		 2025
£
-
1,250
(4,755)		 £
16,241
1,250
(4,755)
12,736
121,111
133,847		 2024
£
(669)
1,923
(11,382)		 £
(36,770)
1,254
(11,382)
(46,898)
168,009
121,111

OXFORD INTERNATIONAL BIOMEDICAL CENTRE LIMITED

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 AUGUST 2025

1 Accounting policies

Charity information

Oxford International Biomedical Centre Limited is a private company limited by guarantee incorporated in England and Wales. The registered office is 3rd Floor Hathaway House, Popes Drive, London, England, N3 1QF.

1.1 Basis of preparation

The financial statements have been prepared in accordance with the charity's governing document, the Companies Act 2006, FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Charities SORP "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)". The charity is a Public Benefit Entity as defined by FRS 102.

The financial statements are prepared in sterling, which is the functional currency of the charity. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2 Going concern

At the time of approving the financial statements, the trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3 Charitable funds

Unrestricted funds are available for use at the discretion of the trustees in furtherance of their charitable objectives.

1.4 Income

Income is recognised when the charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received.

Cash donations are recognised on receipt. Other donations are recognised once the charity has been notified of the donation, unless performance conditions require deferral of the amount. Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation.

Legacies are recognised on receipt or otherwise if the charity has been notified of an impending distribution, the amount is known, and receipt is expected. If the amount is not known, the legacy is treated as a contingent asset.

1.5 Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement, and the amount of the obligation can be measured reliably.

Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges are allocated on the portion of the asset’s use.

OXFORD INTERNATIONAL BIOMEDICAL CENTRE LIMITED

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 AUGUST 2025

1 Accounting policies

(Continued)

1.6 Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computers 25% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the statement of financial activities.

1.7 Impairment of fixed assets

At each reporting end date, the charity reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

1.8 Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.9 Financial instruments

The charity has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the charity's balance sheet when the charity becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities

Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of operations from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

OXFORD INTERNATIONAL BIOMEDICAL CENTRE LIMITED

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 AUGUST 2025

1 Accounting policies

(Continued)

Derecognition of financial liabilities

Financial liabilities are derecognised when the charity’s contractual obligations expire or are discharged or cancelled.

1.10 Employee benefits

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the charity is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.11 Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2 Critical accounting estimates and judgements

In the application of the charity’s accounting policies, the trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3 Income from charitable activities

Unrestricted Unrestricted
funds funds
2025 2024
£ £
Services provided under contract 83,741 116,358
Income from investments
Unrestricted Unrestricted
funds funds
2025 2024
£ £
Interest receivable 1,250 1,923

4 Income from investments

OXFORD INTERNATIONAL BIOMEDICAL CENTRE LIMITED

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 AUGUST 2025

5 Expenditure on charitable activities

Unrestricted Unrestricted
funds funds
2025 2024
£ £
Direct costs
Share of support and governance costs (see note 6)
Support 2,700 133,399
Governance 92,696 2,369
95,396 135,768
Analysis by fund
Unrestricted funds 95,396 135,768
6 Support costs allocated to activities
2025 2024
£ £
Staff costs 33,044 32,167
Depreciation 167 168
USC tutors fees & expenses 53,264 87,702
Rent & Telephone - 6,512
Computer running costs 919 1,149
Scholarships 4,140 3,749
Donation - 500
Bank loan interest 193 650
Sundry 665 802
Governance costs 3,004 2,369
95,396 135,768
Analysed between:
Unrestricted funds 95,396 135,768
7 Net movement in funds 2025 2024
£ £
The net movement in funds is stated after charging/(crediting):
Fees payable for the independent examination of the charity's financial
statements 900 750
Depreciation of owned tangible fixed assets 167 168
8 Trustees

None of the trustees (or any persons connected with them) received any remuneration or benefits from the charity during the year.

OXFORD INTERNATIONAL BIOMEDICAL CENTRE LIMITED

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 AUGUST 2025

9 Employees

The average monthly number of employees during the year was:

2025 2024
Number Number
1 1
Employment costs 2025 2024
£ £
Wages and salaries 31,470 30,644
Other pension costs 1,574 1,523
33,044 32,167

There were no employees whose annual remuneration was more than £60,000.

10 Taxation

The charity is exempt from taxation on its activities because all its income is applied for charitable purposes.

11 Tangible fixed assets

11 Tangible fixed assets
Computers
£
Cost
At 1 September 2024 1,129
At 31 August 2025 1,129
Depreciation and impairment
At 1 September 2024 628
Depreciation charged in the year 167
At 31 August 2025 795
Carrying amount
At 31 August 2025 334
At 31 August 2024 501
12 Debtors
2025 2024
Amounts falling due within one year: £ £
Other debtors 1,769 1,769

OXFORD INTERNATIONAL BIOMEDICAL CENTRE LIMITED

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 AUGUST 2025

13
Loans and overdrafts
Bank loans
Payable within one year
Payable after one year
14
Creditors: amounts falling due within one year
Notes
Bank loans
13
Other taxation and social security
Other creditors
Accruals and deferred income
15
Creditors: amounts falling due after more than one year
Notes
Bank loans
13
16
Retirement benefit schemes
Defined contribution schemes
Charge to profit or loss in respect of defined contribution schemes		 2025
£
4,460
4,460
-
2025
£
4,460
1,268
2,476
31,923
40,127
2025
£
-
2025
£
1,574		 2024
£
9,215
4,760
4,455
2024
£
4,760
1,190
4,948
1,800
12,698
2024
£
4,455
2024
£
1,523

The charity operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the charity in an independently administered fund.

OXFORD INTERNATIONAL BIOMEDICAL CENTRE LIMITED

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 AUGUST 2025

17 Unrestricted funds

The unrestricted funds of the charity comprise the unexpended balances of donations and grants which are not subject to specific conditions by donors and grantors as to how they may be used. These include designated funds which have been set aside out of unrestricted funds by the trustees for specific purposes.

At 1 Incoming Resources At 31 August
September resources expended 2025
2024
£ £ £ £
General funds 106,228 84,991 (95,396) 95,823
Previous year: At 1 Incoming Resources At 31 August
September resources expended 2024
2023
£ £ £ £
General funds 123,715 118,281 (135,768) 106,228

18 Related party transactions

There were no disclosable related party transactions during the year (2024 - none).

19 Cash generated from/(absorbed by) operations

Cash generated from/(absorbed by) operations
Deficit for the year
Adjustments for:
Investment income recognised in statement of financial activities
Depreciation and impairment of tangible fixed assets
Movements in working capital:
(Increase) in debtors
Increase/(decrease) in creditors
Cash generated from/(absorbed by) operations		 2025
£
(10,405)
(1,250)
167
-
27,729
16,241		 2024
£
(17,487)
(1,923)
168
(1,769)
(15,759)
(36,770)

OXFORD INTERNATIONAL BIOMEDICAL CENTRE LIMITED

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 AUGUST 2025

20 Analysis of changes in net funds
At 1 September Cash flows At 31 August
2024 2025
£ £ £
Cash at bank and in hand 121,111 12,736 133,847
Loans falling due within one year (4,760) 300 (4,460)
Loans falling due after more than one year (4,455) 4,455 -
111,896 17,491 129,387